CVRx Inc (CVRX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $17.30M
Last updated: Nov 17, 2026 at 11:03 AM ET
CVRx Inc (CVRX) Stock Forecast
Analysts expect CVRX to earn -$2.07 per share in the fiscal year ending Dec 31, 2026, on revenue of $56.40M. Of 7 analysts, 3 rate the stock Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 2.86, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 43% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 3 | 42.9% |
| Hold | 3 | 42.9% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 14.3% |
- Consensus
- Hold
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 3.7%.
- Fiscal year ending Dec 31, 2026
- -$2.07
- EPS consensus, revenue $56.40M
- Fiscal year ending Dec 31, 2027
- -$1.89
- EPS consensus, revenue $58.46M
- Next report
- Feb 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$2.07 | -$2.09 to -$2.03 | 6 | $56.40M | $56.00M to $56.85M | 6 |
| Dec 31, 2027 | -$1.89 | -$2.06 to -$1.72 | 6 | $58.46M | $55.16M to $60.06M | 6 |
Quarterly Estimates
The EPS consensus rises from -$0.52 for the quarter ending Dec 31, 2026 to -$0.49 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.52 | -$0.53 to -$0.51 | 9 | $12.79M | $11.47M to $15.22M | 9 |
| Mar 31, 2027 | -$0.49 | -$0.57 to -$0.44 | 5 | $13.73M | $11.50M to $14.93M | 5 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 5 upward and 5 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
| Fiscal year ending Dec 31, 2027 | 3 | 2 |
| Quarter ending Mar 31, 2027 | 2 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$2.02.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.07 | -$2.02 | -$2.02 | -$2.02 | -$2.02 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.89 | -$1.89 | -$1.89 | -$1.89 | -$1.89 | N/A |
| Quarter ending Mar 31, 2027 | -$0.49 | -$0.50 | -$0.50 | -$0.50 | -$0.50 | N/A |
Frequently Asked Questions About CVRX
What is the CVRX stock forecast?
Consensus analyst estimates put CVRX's EPS at -$2.07 for the fiscal year ending Dec 31, 2026, on revenue of $56.40M. The consensus rating from 7 analysts is Hold.
How do analysts rate CVRX stock?
Of 7 analysts covering CVRX, 0 rate it Strong Buy, 3 Buy, 3 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from CVRX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.07, with estimates from -$2.09 to -$2.03 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.89, with estimates from -$2.06 to -$1.72 from 6 analysts.
What revenue do analysts expect from CVRX next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $56.40M, with estimates from $56.00M to $56.85M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $58.46M, with estimates from $55.16M to $60.06M.
How many analysts cover CVRX?
7 analysts rate CVRX stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CVRX pages: Overview, Earnings, Forecast, Financials, Competitors